A day late and a dollar short on monkeypox

Ahead of the global eruption of monkeypox cases, outbreaks of the disease were already increasing in West and Central Africa, where it has sporadically appeared for decades. For researchers in the region, it’s a familiar cycle, like the West African Ebola outbreak that began in 2013, when attention and resources to an existing pathogen only increase after the disease threatens the global north. Read more.


Three reasons for unprecedented global hunger

Global hunger is at unprecedented levels, with an estimated 276 million people facing severe food shortages — and at least three countries at risk of famine. With food prices soaring, supply chains disrupted and the conflict in Ukraine blocking access to vital reserves, experts fear the crisis could deepen. How did we get here and what can be done about it? Read more.


The battle for Paxlovid

Rich countries are snapping up available Covid-19 treatments, leaving the rest of the world months away from gaining access. The wait in some middle-income countries could be even longer.

“We still have deaths every day, and coming into winter it will increase,” said Luis Villarroel Villalón, who leads a nonprofit in Chile that provides legal services. His is among the dozens of middle-income countries looking at a wait, which could stretch well into 2023, for the new treatments, particularly Pfizer’s oral antiviral, Paxlovid. “Lives could be saved through Paxlovid,” said Villalón. Read more.


Calls to restart testing for parasitic disease at U.S. CDC

American experts on neglected tropical diseases are warning that the Centers for Disease Control and Prevention's suspension of testing for most parasitic infections, which has been ongoing now for more than seven months, is delaying diagnoses and treatment and affecting patient care. But there is still no timeline for resuming most of the tests. Read more.


TRIPS waiver compromise tabled at WTO finds few takers

Discussions began last week within the World Trade Organization over a proposal to temporarily waive patent protections on COVID-19 vaccines. Even as WTO officials press for a resolution ahead of a long-delayed ministerial conference in June, the halting reactions of members to the document signal that reaching consensus in a month — or at all — will not be easy. Read more.


As Uganda’s schools reopen, Museveni’s education promises ring hollow

In March 2020, before the first COVID-19 case was even recorded in Uganda, President Yoweri Museveni went on national television to announce a country-wide closure of schools. Calling schools the “perfect grounds for new infections,” he said he was making the “move early to avoid the stampede.”

Most of the country’s classrooms would remain closed for 22 months, one of the longest COVID-related shutdowns in the world.

They finally reopened in January, and educators are still assessing the fallout. The damage to State House—Uganda’s executive branch—meanwhile, is already clear. With his willingness to keep schools shuttered even as he lifted other restrictions, Museveni undermined his commitment to education as a top priority of his political agenda.

Read more.


Global Fund called to account for stock shortages in Kenya, Mozambique

Recent audits of grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria in Kenya and Mozambique have identified gaps in the procurement and supply chain processes in both countries, contributing to essential drugs and commodities going out of stock.

Dismayed by the results, civil society groups are demanding accountability from the Global Fund. Read more.